Alar Pharmaceuticals (TWO:6785) received a notice of acceptance from the UAE Ministry of Economy and Tourism for a patent covering long-acting injectable formulations of ketamine pamoate salts.
The company said the patent could facilitate its international licensing business, according to a Friday Taiwan Exchange filing.